CS-2010

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameCS-2010
Drug Alias NameCS-2010CS2010
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionSomatostatin receptor 2 modulatorsT cell surface glycoprotein CD3 modulatorsDelta-like protein 3 modulators
TargetsSomatostatin receptor 2T cell surface glycoprotein CD3Delta-like protein 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCstone Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesCstone Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A